Literature DB >> 10648173

Purification and characterization of human Syk produced using a baculovirus expression system.

D Baldock1, B Graham, M Akhlaq, P Graff, C E Jones, K Menear.   

Abstract

The cytoplasmic tyrosine kinase p72syk (Syk) plays an essential role in signaling via a variety of immune and nonimmune cell receptors. Syk is activated in response to the engagement of the appropriate cell surface receptors and can phosphorylate downstream targets and recruit additional SH2-domain-containing proteins. In order to study the characteristics of Syk in vitro, we have overexpressed untagged, full-length human Syk in a recombinant baculovirus expression system. The enzyme was purified to 95% purity using a novel two-step affinity chromatography process using reactive yellow and phosphotyrosine columns. Yields of 3-10 mg purified Syk were obtained from 1 liter of infected insect cells. Western blotting, internal protein sequencing, and the specific tyrosine phosphorylation of a Syk peptide substrate indicated authenticity of the purified protein. The enzymatic properties of Syk were in good agreement with published data for the human enzyme, as the apparent K(m) of Syk for ATP was 10 microM and the peptide substrate was 3 microM. The recombinant protein also showed similar biochemical characteristics to the native protein isolated from B-cells such as autophosphorylation. Proteolytic cleavage of purified recombinant Syk was used to generate the kinase domain by micro-calpain. We therefore describe an efficient expression system and purification methodology to produce biologically active human Syk. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10648173     DOI: 10.1006/prep.1999.1171

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  3 in total

1.  Expression of Syk and MAP4 proteins in ovarian cancer.

Authors:  Siwei Zhang; Suha Deen; Sarah J Storr; Anqi Yao; Stewart G Martin
Journal:  J Cancer Res Clin Oncol       Date:  2019-02-08       Impact factor: 4.553

2.  WIP regulates signaling via the high affinity receptor for immunoglobulin E in mast cells.

Authors:  Alexander Kettner; Lalit Kumar; Inés M Antón; Yoji Sasahara; Miguel de la Fuente; Vadim I Pivniouk; Hervé Falet; John H Hartwig; Raif S Geha
Journal:  J Exp Med       Date:  2004-02-02       Impact factor: 14.307

3.  Selective inhibition of spleen tyrosine kinase (SYK) with a novel orally bioavailable small molecule inhibitor, RO9021, impinges on various innate and adaptive immune responses: implications for SYK inhibitors in autoimmune disease therapy.

Authors:  Cheng Liao; Jonathan Hsu; Yong Kim; Dong-Qing Hu; Daigen Xu; Jun Zhang; Achal Pashine; John Menke; Toni Whittard; Natasha Romero; Theresa Truitt; Michelle Slade; Christine Lukacs; Johannes Hermann; Mingyan Zhou; Matthew Lucas; Satwant Narula; Julie DeMartino; Seng-Lai Tan
Journal:  Arthritis Res Ther       Date:  2013-10-04       Impact factor: 5.156

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.